BRÈVE publiée le 20/11/2024 à 18:43, il y a 1 année 11 mois Fuller, Smith & Turner PLC Executes Share Buyback Voting Rights Share Buyback Treasury Shares Numis Securities Fuller’s
BRÈVE publiée le 20/11/2024 à 18:43, il y a 1 année 11 mois Fuller, Smith & Turner PLC procède à un rachat d'actions Actions Propres Rachat D'actions Droit De Vote Fuller Numis Titres
COMMUNIQUÉ DE PRESSE publié le 20/11/2024 à 18:38, il y a 1 année 11 mois Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 2,500 'A' ordinary shares at an average price of 694.0000 GBp each, as part of its share buyback programme Voting Rights London Stock Exchange Share Buyback Numis Securities Limited Fuller Smith Turner PLC
BRÈVE publiée le 19/11/2024 à 18:10, il y a 1 année 11 mois Fuller, Smith & Turner PLC Engages in Share Buyback London Stock Exchange Ordinary Shares Share Buyback Treasury Shares Fuller, Smith & Turner
BRÈVE publiée le 19/11/2024 à 18:10, il y a 1 année 11 mois Fuller, Smith & Turner PLC se lance dans un rachat d'actions Actions Propres Rachat D'actions Actions Ordinaires Bourse De Londres Fuller, Smith Et Turner
COMMUNIQUÉ DE PRESSE publié le 19/11/2024 à 18:05, il y a 1 année 11 mois Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of 'A' ordinary shares as part of share buyback program on the London Stock Exchange through Numis Securities Limited London Stock Exchange Share Buyback Numis Securities Limited FSTA Fuller Smith Turner
BRÈVE publiée le 18/11/2024 à 18:59, il y a 1 année 11 mois Fuller, Smith & Turner PLC Executes Share Buyback Voting Rights London Stock Exchange Share Buyback Treasury Shares Fuller, Smith & Turner
BRÈVE publiée le 18/11/2024 à 18:59, il y a 1 année 11 mois Fuller, Smith & Turner PLC procède à un rachat d'actions Actions Propres Rachat D'actions Droit De Vote Bourse De Londres Fuller, Smith Et Turner
COMMUNIQUÉ DE PRESSE publié le 18/11/2024 à 18:54, il y a 1 année 11 mois Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC purchases 10,056 'A' ordinary shares of 40p each on the London Stock Exchange as part of its buyback program London Stock Exchange Shares Fuller, Smith & Turner PLC Purchase Buyback Program
BRÈVE publiée le 15/11/2024 à 17:58, il y a 1 année 11 mois Fuller, Smith & Turner PLC Executes Share Buyback Ordinary Shares Share Buyback Numis Securities Market Regulation Fuller’s
Publié le 04/11/2026 à 18:00, il y a 9 heures 33 minutes The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Publié le 04/11/2026 à 18:00, il y a 9 heures 33 minutes L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Publié le 04/11/2026 à 17:44, il y a 9 heures 49 minutes Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Publié le 04/11/2026 à 23:10, il y a 4 heures 23 minutes Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Publié le 04/11/2026 à 23:00, il y a 4 heures 33 minutes Viemed Healthcare Announces Third Quarter 2026 Financial Results
Publié le 04/11/2026 à 22:15, il y a 5 heures 18 minutes Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Publié le 04/11/2026 à 22:05, il y a 5 heures 28 minutes Stabilis Solutions Announces Third Quarter 2026 Results
Publié le 05/11/2026 à 03:10, il y a 23 minutes SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Publié le 05/11/2026 à 00:02, il y a 3 heures 31 minutes EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Publié le 04/11/2026 à 19:41, il y a 7 heures 52 minutes EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Publié le 04/11/2026 à 19:25, il y a 8 heures 8 minutes Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Publié le 04/11/2026 à 18:43, il y a 8 heures 50 minutes EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
